Serum infliximab concentrations and disease activity: a descriptive study of patients with psoriasis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Serum infliximab concentrations and disease activity: a descriptive study of patients with psoriasis

Published:2015-11-08 Issue:1 Volume:174 Page:198-200
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Dannepond C.¹,Ternant D.²,Maruani A.¹³,Machet L.¹³,Paintaud G.²,Samimi M.¹⁴

Affiliation:

1. Dermatology Department University François Rabelais Hospital of Tours Tours France

2. CNRS GICC UMR 7292 Laboratory of Pharmacology Toxicology Hospital of Tours Tours France

3. INSERM Imagerie et Cerveau UMR U930 Tours France

4. INRA ISP UMR 1282 Université François Rabelais Tours France

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.13831

Reference15 articles.

1. Long-term durability and dose escalation patterns in infliximab therapy for psoriasis

2. Variability factors in the clinical response to recombinant antibodies and IgG Fc-containing fusion proteins

3. Infliximab concentration monitoring improves the control of disease activity in rheumatoid arthritis

4. Therapeutic drug monitoring in inflammatory bowel disease;Kopylov U;Ann Gastroenterol,2014

5. Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology;Therapeutic Drug Monitoring;2024-04-17

2. Association between infliximab concentrations and clinical response in psoriasis: a prospective cohort study;Journal of Dermatological Treatment;2019-11-20

3. Rationale for Therapeutic Drug Monitoring of Biopharmaceuticals in Inflammatory Diseases;Therapeutic Drug Monitoring;2017-08

4. Therapeutic Drug Monitoring of Biopharmaceuticals May Benefit From Pharmacokinetic and Pharmacokinetic–Pharmacodynamic Modeling;Therapeutic Drug Monitoring;2017-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3